CD8+CD28− Lymphocytes in Peripheral Blood and Serum Concentrations of Soluble Interleukin 6 Receptor are Increased in Patients with Graves’ Orbitopathy and Correlate with Disease Activity
- 18 October 2011
- journal article
- research article
- Published by Taylor & Francis in Endocrine Research
- Vol. 37 (2) , 89-95
Abstract
Background. The extrathyroid, orbital manifestation of Graves’ disease (GD)—Graves’ orbitopathy (GO)—presents a difficult clinical problem. The immunological status of GO patients is still under investigation. The aim of this study was to assess the serum concentration of interleukin 6 (IL-6), soluble interleukin 6 receptor (sIL-6R), and CD8+CD28− lymphocytes in GO patients and to evaluate if these parameters were associated with disease activity. Patients. Thirty-nine patients (29 women and 10 men, aged 24–71, mean 50.18) with newly diagnosed GD were enrolled in the study. Active GO was diagnosed in 20 patients. The control group included 12 healthy individuals. Methods. Serum concentrations of IL-6 and sIL-6R were estimated by ELISA. Percentages of CD8+CD28− lymphocytes in peripheral blood were assessed by flow cytometry. Results. Mean serum IL-6 and sIL-6R concentrations were significantly higher in all GD patients and in GO and non-GO patients than in normal controls. In all GD patients and the non-GO group, serum IL-6 and sIL-6R concentrations were significantly reduced after efficient treatment. In GO patients, only serum sIL-6R concentration was significantly lower after efficient treatment. In all GD patients, the mean percentage of CD8+CD28− lymphocytes was significantly lower after efficient treatment. In GO patients, the mean percentage of CD8+CD28− lymphocytes was significantly higher than in the non-GO group or in normals. Moreover, in the GO group, the mean percentage of CD8+CD28− lymphocytes was significantly lower after treatment. Conclusion. Our results have shown that CD8+CD28− lymphocyte percentage in peripheral blood and serum concentration of sIL-6R are increased in GO patients and correlate with disease activity.Keywords
This publication has 16 references indexed in Scilit:
- PGE2 Induces IL-6 in Orbital Fibroblasts through EP2 Receptors and Increased Gene Promoter Activity: Implications to Thyroid-Associated OphthalmopathyPLOS ONE, 2010
- Immunopathogenesis of Thyroid Eye Disease: Emerging ParadigmsSurvey of Ophthalmology, 2010
- Graves' OphthalmopathyNew England Journal of Medicine, 2010
- Orbital Fibroblasts from Patients with Thyroid-Associated Ophthalmopathy Overexpress CD40: CD154 Hyperinduces IL-6, IL-8, and MCP-1Investigative Ophthalmology & Visual Science, 2009
- CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patientsMedical Oncology, 2009
- Inhibitory CD8+ T cells in autoimmune diseaseHuman Immunology, 2008
- Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T CellsJournal of Clinical Immunology, 2008
- CD8+CD28−, suppressive T cells in systemic lupus erythematosusLupus, 2008
- Proliferation and apoptosis of human CD8+CD28+ and CD8+CD28− lymphocytes during agingExperimental Gerontology, 2004
- Rapid turnover of the CD8 + CD28 - T-cell subset of effector cells in the circulation of patients with head and neck cancerCancer Immunology, Immunotherapy, 2003